Clinical Trials Browser

Terminated × INDUSTRY × Immunotherapy × Clear all

NCT02054520 2023-04-18

Immunotherapy Study for Patients With Stage IV Melanoma

Phase 2 Terminated

47 enrolled 16 charts

Melanoma

NCT00089856 2008-11-05

GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer

Phase 3 Terminated

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms